Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.45 USD | -0.27% | -2.91% | +16.58% |
Jun. 07 | BWX Technologies' Unit Submits Drug Master File for Actinium-225 to FDA | MT |
May. 07 | BWX Technologies, Inc. Appoints Nicole W. Piasecki to the Governance Committee | CI |
Evolution of the average Target Price on BWX Technologies, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering BWX Technologies, Inc.
Deutsche Bank Securities | |
Truist Securities | |
Alembic Global | |
Barclays | |
Baird | |
Credit Suisse | |
Maxim | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- BWXT Stock
- Consensus BWX Technologies, Inc.